Shares of Option Care Health (NASDAQ: OPCH) experienced a notable decline of 26.4% during the afternoon session following the release of disappointing first-quarter results for 2026. The company’s performance revealed a modest year-over-year revenue growth of 1.3%, totaling $1.35 billion, which fell short of analysts’ expectations. Although the adjusted earnings per share (EPS) of $0.40 surpassed forecasts, it marked no growth compared to the same quarter last year. This stagnation raised concerns among investors, especially as the company lowered its full-year revenue guidance to a midpoint of $5.73 billion, falling below previous estimates and representing a 3.6% shortfall from analyst forecasts.
The negative market reaction was swift, with the company’s shares closing the day at $19.86, marking a decrease of 26.1% from the previous close. This sharp decline has sparked discussions among analysts regarding the potential buying opportunities it might present, given that significant price drops can sometimes signal a favorable entry point for quality stocks.
Analyzing the broader market impact, shares of Option Care Health have exhibited relatively low volatility, with only seven movements exceeding 5% in the past year. This recent decline reflects a significant shift in market sentiment towards the company’s prospects. In contrast, the biggest gain in the last year occurred four months prior, when the stock rose by 8.9% following an announcement of an increased share repurchase authorization to $1 billion, along with preliminary results for 2025 that indicated net revenue estimates between $1.46 billion and $1.47 billion. At that time, analysts at Citizens and Morgan Stanley raised their price targets for the stock to $38.00, and Citizens maintained a “Market Outperform” rating.
Year-to-date, Option Care Health shares have fallen by 37.1%, currently trading at $20.28, which is 44.6% below the 52-week high of $36.59 reached in January 2026. However, despite the ongoing decline, investors who purchased $1,000 worth of shares five years ago would see a modest appreciation in their investment, now valued at $1,064.
Market analysts are now demanding a deeper examination of Option Care Health’s future, as the lowered revenue guidance and the first-quarter revenue miss highlight potentially troubling trends for the company and its stakeholders.
